A phase III, randomized, open-label, 500-subject clinical trial of minimally invasive surgery plus rt-PA in the treatment of intracerebral haemorrhage.
Active, no longer recruiting
Phase of Trial: Phase III
Latest Information Update: 24 Aug 2017
At a glance
- Drugs Alteplase (Primary)
- Indications Intracranial haemorrhages
- Focus Adverse reactions; Therapeutic Use
- Acronyms MISTIE III
- 17 Aug 2017 Planned End Date changed from 1 Sep 2019 to 1 Aug 2018.
- 17 Aug 2017 Planned primary completion date changed from 1 Sep 2018 to 1 Aug 2018.
- 17 Aug 2017 Status changed from recruiting to active, no longer recruiting.